Navigation Links
Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
Date:9/30/2008

NEW YORK and BUDAPEST, Hungary, Sept. 30 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter Plc today announced preliminary top-line results from a phase II clinical trial of cariprazine (RGH-188), an investigational antipsychotic, in patients with acute mania associated with bipolar I disorder. For the primary endpoint, the Young Mania Rating Scale (YMRS), the data showed that patients with acute manic episodes treated with cariprazine experienced significant symptom improvement compared to placebo patients within the first week of treatment and at each subsequent time point studied. Further analyses of the data will be completed in the coming weeks. Cariprazine is also currently being investigated in clinical studies in schizophrenia.

(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )

"These exciting preliminary results in patients with bipolar mania demonstrate the potential of cariprazine as a novel antipsychotic agent," stated Marco Taglietti, M.D., Executive Vice President and Chief Medical Officer, Forest Laboratories, Inc. "Therefore, we will continue to investigate and characterize the therapeutic benefits of cariprazine, a unique molecule with high selectivity for the D3 versus the D2 dopamine receptors.

"Dopamine system stabilizer cariprazine clearly proved its effect in this study," commented Zsolt Szombathelyi, M.D., Research Director of Gedeon Richter Plc. "The result confirms Richter's CNS research concept and the clinical opportunity of a dual acting D3/D2 compound."

About the Study

The phase II double-blind, placebo-controlled, flexible-dose study evaluated the
'/>"/>

SOURCE Gedeon Richter Plc; Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
2. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
3. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
4. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
5. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
6. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
7. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
8. Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... N.C. , Dec. 23, 2014  Medical Science ... As the key link between the medical device industry ... even more in the coming years as the device ... According to research by benchmarking firm, Best ... can gain an important edge is by harnessing new ...
(Date:12/22/2014)... Dec. 22, 2014   TRU-D SmartUVC LLC, ... disinfection robot, announced today that the General Services Administration ... November 2019.   This newly formed agreement ... levels of government purchasers, including Department of Veteran Affairs ... Homeland Security contacts purchasing solutions for the Ebola effort ...
(Date:12/22/2014)... Dec. 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering, developing and commercializing innovative therapies addressing ... issued the following open letter to shareholders from ... Med. Sc. Dear RXi Shareholders, ... of inaccurate statements posted on certain social media ...
Breaking Medicine Technology:Role of Medical Science Liaisons Evolving in Medical Device Sector 2TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
... Nov. 3, 2010 Par Pharmaceutical Companies, Inc. (NYSE: ... ended September 30, 2010. For the third quarter ... $234.4 million and income from continuing operations of $30.7 million, ... milestone payment to Tris Pharma, Inc., a $2.3 million payment ...
... OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics ... it has been awarded $1.2 million to support ... Qualifying Therapeutic Discovery Project ("QTDP") program.  All of ... an award.  The funds will be used to ...
Cached Medicine Technology:Par Pharmaceutical Companies Reports Third Quarter 2010 Results 2Par Pharmaceutical Companies Reports Third Quarter 2010 Results 3Par Pharmaceutical Companies Reports Third Quarter 2010 Results 4Par Pharmaceutical Companies Reports Third Quarter 2010 Results 5Par Pharmaceutical Companies Reports Third Quarter 2010 Results 6Par Pharmaceutical Companies Reports Third Quarter 2010 Results 7Par Pharmaceutical Companies Reports Third Quarter 2010 Results 8Par Pharmaceutical Companies Reports Third Quarter 2010 Results 9Par Pharmaceutical Companies Reports Third Quarter 2010 Results 10Par Pharmaceutical Companies Reports Third Quarter 2010 Results 11OncoMed Pharmaceuticals Awarded Five Therapeutic Discovery Project Grants Totaling $1.2 Million 2OncoMed Pharmaceuticals Awarded Five Therapeutic Discovery Project Grants Totaling $1.2 Million 3
(Date:12/25/2014)... December 26, 2014 The ... combines beauty, strength and durability. Today, the business ... which is valid until Jan. 30, 2015. , ... of traditional hardwood. BambooFlooringChina.com is a well-known brand ... consumers worldwide to find a reliable bamboo flooring ...
(Date:12/25/2014)... “Every three months the trends for ... evening dress will be one of the hottest styles in ... says. Today, the company releases 26 A-line sweetheart evening dresses, ... off. , “We are trying our best to help ... latest designs. Along with affordable prices, we provide discounted delivery ...
(Date:12/25/2014)... 25, 2014 Recently, BellasDress ... all its wedding dresses. BellasDress has chosen their best-selling ... gift choices for the holiday season. , Now, ... suitable wedding gowns here at discount prices. The business ... at its website. , “All our elegant ...
(Date:12/25/2014)... updated its blog to provide professional shopping tips on wedding and ... LunaDress.co.uk come with big discounts, up to 80 percent off. , ... to be a most exciting memory and can show off a ... a wedding. On the updated fashion blog, ladies can now find ... day . , Going out with friends to a party is ...
(Date:12/25/2014)... -- Among early stage breast cancer patients who undergo ... percent will eventually develop leukemia as a result of ... comes from a review of more than 20,000 breast ... suggests that the risk for developing treatment-related leukemia, though ... "The frequency of bone marrow cancers such as ...
Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... , ... A. Abelson says proposed curbs address an illusion instead of the real problem — ... ... personal injury lawyer in Maryland and Washington, DC, says proposed limits on damage awards ...
... benefit actually stems from overall healthier lifestyle remains unclear, , ... for infants are numerous and well-known, but researchers are finding ... mom,s health as well. , In fact, the latest study ... amounts of abdominal fat, even decades later. , The study, ...
... ... ... , ... DAYTON, N.J. , March 5 Mincing Overseas Spice Company of ...
... ... Link is Citizen Preparedness , ... Sacramento, CA (PRWEB) March 5, 2010 -- A majority of Californians have ... not done enough to make their homes safer and guard their personal finances in ...
... ... ... ... ...
... stem from the devices or patient error, FDA panel says ... insulin pumps used to treat diabetes should try to supply ... problems with the devices, an advisory panel to the U.S. ... devices are required to report when a device malfunctions or ...
Cached Medicine News:Health News:Congressional Concession On Medical Malpractice Awards Will Not Lower Health Care Costs And Will Hurt Patients' Rights, Washington, DC Attorney Says 2Health News:Congressional Concession On Medical Malpractice Awards Will Not Lower Health Care Costs And Will Hurt Patients' Rights, Washington, DC Attorney Says 3Health News:Breast-Feeding Helps Mom Stay Slimmer Later in Life 2Health News:Breast-Feeding Helps Mom Stay Slimmer Later in Life 3Health News:Mincing Overseas Spice Company Voluntarily Recalls Two Lots of Black Pepper 2Health News:Study Reveals Californians Must Increase Earthquake Preparedness; Less Than 20 Percent Have Prepared Their Homes; Only 40 Percent Have Sufficient Water 2Health News:Study Reveals Californians Must Increase Earthquake Preparedness; Less Than 20 Percent Have Prepared Their Homes; Only 40 Percent Have Sufficient Water 3Health News:Study Reveals Californians Must Increase Earthquake Preparedness; Less Than 20 Percent Have Prepared Their Homes; Only 40 Percent Have Sufficient Water 4Health News:Study Reveals Californians Must Increase Earthquake Preparedness; Less Than 20 Percent Have Prepared Their Homes; Only 40 Percent Have Sufficient Water 5Health News:Endo to Present at Cowen and Company 30th Annual Health Care Conference 2Health News:Endo to Present at Cowen and Company 30th Annual Health Care Conference 3Health News:More Info Needed on Problems With Insulin Pumps 2Health News:More Info Needed on Problems With Insulin Pumps 3
0-3.5 LPM Oxygen Flowmeter with Ohmeda male inlet...
0-15 LPM Oxygen Flowmeter 1/8" NPT female inlet...
(1-15 LPM), 50 psi, 1/ 8" NPT female back inlet...
(1/4-15 LPM). 50 psi back inlet, wall mounted, 1/8" NPT female....
Medicine Products: